Physician profile
Devin Christopher Bourne
NPI 1548910177
$245.93
in general payments reported to CMS, 2019-2025
11 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $70.88 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $42.91 | 2025 | Inspire |
| Novo Nordisk INC | $34.87 | 2024-2025 | Wegovy |
| Biocon Biologics INC | $28.90 | 2024 | Hulio |
| Hologic Sales and Service, LLC | $22.31 | 2024 | Aptima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.86 | 2025 | |
| Paratek Pharmaceuticals, INC. | $18.45 | 2025 | Nuzyra, Xhance |
| Exact Sciences Corporation | $17.32 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $16.62 | 2025 | |
| Lilly USA, LLC | $14.82 | 2025 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $13.97 | 2025 | Airsupra |
| Verity Pharmaceuticals INC. | $13.90 | 2025 | Tlando |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Bourne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.